The European Patent Office (EPO) has published patent application EP4709726A1, filed by Foghorn Therapeutics Inc., concerning therapeutic compounds and their uses. The publication details the inventors, International Patent Classification (IPC) codes including C07D 471/04, C07D 519/00, A61K 31/5025, and A61P 35/00, and lists designated states across Europe where the patent is applicable.

This publication represents a new patent filing for Foghorn Therapeutics and does not impose immediate compliance obligations on regulated entities. However, it is relevant for entities operating in the pharmaceutical and biotechnology sectors, particularly those involved in drug development and intellectual property management, as it pertains to novel therapeutic compounds. Compliance officers in these sectors should note this publication as part of ongoing landscape monitoring for competitive and technological developments.